Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression-Reference-Cited by-同舟云学术

Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression

Published:2021-10 Issue:5 Volume:54 Page:944-951
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Huang Wei-Chieh^ORCID,Huang Chun-Kai,Huang Sung-Hsi^ORCID,Lin Shu-Wen^ORCID,Ou Shyh-Tyan,Chen Yi-Ting,Chen Ya-Wen,Chang Shu-Yuan,Liu Wen-Chun,Sun Hsin-Yun^ORCID,Hung Chien-Ching

Funder

UBI Pharma Inc

Hsinchu, Taiwan

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference38 articles.

1. Combined global demand forecasts for antiretroviral medicines and HIV diagnostics in low- and middle-income countries from 2015 to 2020;World Health Organization,2016

2. The role of ARV associated adverse drug reactions in influencing adherence among HIV-infected individuals: a systematic review and qualitative meta-synthesis;Li;AIDS Behav,2017

3. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study;van Lunzen;AIDS,2016

4. Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring;Gutierrez;Clin Infect Dis,2005

5. Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan;Wu;PloS One,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of antiretroviral drugs for the management of human immunodeficiency infection;Therapeutic Drug Monitoring;2024

2. Study on the Clinical Efficacy and Safety of Efavirenz Reduced Dose in HIV-Infected Patients;Advances in Clinical Medicine;2024